Discover and read the best of Twitter Threads about #T1DM
Most recents (6)
While the fictional boss is investigating a murder-mystery, @oceankripa is doing the real work with @SalilVarshney7 @deepapli1 & others investigating the potential role for #ghrelin in hypoglycemia unawareness associated with recurrent hypoglycemia. #T1DM doi.org/10.3389/fendo.… 
Recurrent episodes of insulin-induced hypoglycemia in patients with diabetes can result in hypoglycemia-associated autonomic failure, characterized by a compromised response to hypoglycemia by counterregulatory hormones (counterregulatory response) and hypoglycemia unawareness.
This so-called HAAF is a leading cause of morbidity in diabetes and often hinders optimal regulation of blood glucose levels. Yet, the molecular pathways underlying HAAF remain incompletely described.
This week is #MentalHealthAwarenessWeek
Today’s short thread is about how living with #diabetes can affect psychological well-being🧵
Plus how #HCPs can effectively assess and support people living with the condition👩
Today’s short thread is about how living with #diabetes can affect psychological well-being🧵
Plus how #HCPs can effectively assess and support people living with the condition👩
1)
Living with #diabetes increases the risk of variable mental health conditions.
For this thread, we will be focusing on #depression , #anxiety and #diabetesdistress🔎
Living with #diabetes increases the risk of variable mental health conditions.
For this thread, we will be focusing on #depression , #anxiety and #diabetesdistress🔎
2)
The ‘Diabetes is Serious Report’ led by @DiabetesUK highlighted that almost half (47%) of people with #diabetes experience difficulties managing their condition.
Those from more deprived areas are at a higher risk🔼
The report is available at:
…production.s3.eu-west-1.amazonaws.com/resources-s3/p…
The ‘Diabetes is Serious Report’ led by @DiabetesUK highlighted that almost half (47%) of people with #diabetes experience difficulties managing their condition.
Those from more deprived areas are at a higher risk🔼
The report is available at:
…production.s3.eu-west-1.amazonaws.com/resources-s3/p…
Up next is "Healthcare Disparities in Cardiovascular Disease: Social and Nutrition Deserts" by Joshua J. Joseph, MD, MPH, FAHA (@joshuajosephmd), moderated by S. Sethu K. Reddy, MD (@endocrineguru) at #AACECVMET #AACE #Endotwitter
@joshuajosephmd @endocrineguru There are higher rates of diabetes mortality (2-fold death disparity) in rural areas as compared to urban areas, and a higher mortality in Black patients compared to White patients. #AACECVMET #AACE #HealthDisparities
@joshuajosephmd @endocrineguru Diabetes prevalence & hospital admissions correlate w/ residential security maps. The 1930s Home Owners Loan Corporation redlining score has an impact today: 1 unit-higher HOLC grades assoc w/ 54% higher DM mortality & 67% higher rate of diabetes years of life lost #AACECVMET
1) Welcome to a new #accredited (0.75h CE/#CME) #tweetorial on challenging case presentations for pts with #cardiometabolic disease, #CaReMe #FOAMed.
Our expert author is Claire Davies. @claireyrivs is a specialist diabetes & endocrinology #pharmacist working in Gateshead in 🇬🇧.
Our expert author is Claire Davies. @claireyrivs is a specialist diabetes & endocrinology #pharmacist working in Gateshead in 🇬🇧.
2) She is a member of UKCPA Diabetes & Endocrinology committee @UKCPADiabetes & works across #diabetes, #endocrinology, & emergency/acute care in Secondary Care. She is currently involved in development of regional guidelines & education to support medicines optimisation for PLWD
3a) This program is intended for healthcare professionals and is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company.
1) Welcome to a new #accredited #tweetorial on Cardiorenal Disease in T2D & the Impact of Blocking the MR in Patients w/DKD, another CE/#CME program by one of the @GoggleDocs, this time our friend @AmarPut, Diabetes & Endocrine Consultant in the West Midlands 🇬🇧. #CaReMe #FOAMed
2) This program is supported by an educational grant from Bayer & is intended for #healthcare providers. Author disclosures can be found at ckd-ce.com/disclosures/. Prior programs, still available for CE/#CME credit, are at ckd-ce.com. CE/#CME credit 🇬🇧🇪🇺🇨🇦🇺🇸
3) So first – the ‘triple threat’ . . . We know of the link between the 🫀 and the kidneys and the ‘#cardiorenal’ syndrome, but what about in the setting of #diabetes?
Welcome to our final Goggledocs tweetorial from this #EASD2021 takeover!
Over the last few days we have discussed all things cardio-reno-metabolic including SGLT2s, GLP1s, dual agonists, triple agonists….but not mentioned much about type 1 diabetes…
Over the last few days we have discussed all things cardio-reno-metabolic including SGLT2s, GLP1s, dual agonists, triple agonists….but not mentioned much about type 1 diabetes…
So today we are going to end on a cardiometabolic focused look at Type 1 Diabetes with data from #EASD2021 interwoven in... stay tuned!
One of the key sessions and guidance from @EASDnews #EASD2021 was the formalized joint ADA-EASD consesnsus report for management of type 1 diabetes… care.diabetesjournals.org/content/early/…
